1. Home
  2. MSA vs GPCR Comparison

MSA vs GPCR Comparison

Compare MSA & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSA Safety Incorporated

MSA

MSA Safety Incorporated

HOLD

Current Price

$177.71

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$88.85

Market Cap

6.5B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSA
GPCR
Founded
1914
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.5B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
MSA
GPCR
Price
$177.71
$88.85
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$185.25
$103.09
AVG Volume (30 Days)
220.6K
1.2M
Earning Date
02-13-2026
02-26-2026
Dividend Yield
1.18%
N/A
EPS Growth
3.07
N/A
EPS
7.10
N/A
Revenue
$1,863,597,000.00
N/A
Revenue This Year
$4.58
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
$25.37
N/A
Revenue Growth
3.31
N/A
52 Week Low
$127.86
$13.22
52 Week High
$185.54
$94.90

Technical Indicators

Market Signals
Indicator
MSA
GPCR
Relative Strength Index (RSI) 59.33 70.86
Support Level $176.10 $87.00
Resistance Level $185.54 $94.77
Average True Range (ATR) 3.58 5.08
MACD -0.18 0.09
Stochastic Oscillator 63.19 79.65

Price Performance

Historical Comparison
MSA
GPCR

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The products include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems. End markets include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company's reportable geographic segments are Northern North America; Latin America; Europe, Middle East & Africa; and Asia Pacific. The company's operating segments have been aggregated into three reportable segments: Americas, International, and Corporate. Geographically the company generates the majority of its revenue from the United States.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: